Unreported / Non-Citable
Background
Plaintiffs filed this antitrust action on April 30, 2026, challenging the August 7, 2025 Skydance-Paramount merger and the anticipated Paramount-Warner Bros. Discovery merger under Section 7 of the Clayton Act. The court previously dismissed the original complaint on August 5, 2026, finding plaintiffs lacked Article III and antitrust standing. The court identified only one concrete injury—a historical price increase on Paramount+—but held it was not fairly traceable to either merger because two plaintiffs did not subscribe to Paramount+ and the increase was not linked to the transactions. The court granted leave to amend.
Plaintiffs filed the First Amended Complaint (FAC) on August 14, 2026, narrowing their market definitions: replacing "premium video distribution" with "direct-to-consumer subscription streaming services," "national television news programming" with "paid national television news," and "theatrical distribution" with "consumer market for first-run theatrical motion pictures." The FAC also added allegations that Paramount's "new management" adopted a post-acquisition pricing strategy emphasizing average revenue per user (ARPU) and profitability to connect the Skydance-Paramount merger to the January 2026 Paramount+ price increase. Defendants moved to dismiss the FAC on the same standing grounds.
The Court’s Holding
The court granted the motion to dismiss the FAC, focusing on antitrust standing and declining to reach other arguments. To establish antitrust standing, a plaintiff must show "antitrust injury"—injury of the type the antitrust laws were intended to prevent—requiring a plausible causal link between the unlawful conduct and the plaintiff's injury that flows from the anticompetitive nature of the conduct. The court evaluated two theories of harm: (1) the Paramount+ price increase paid by plaintiffs Marazzo and Rubinsohn, and (2) generalized threats to competition from the mergers.
As to the price increase, the court found it could not support standing to challenge the Paramount-Warner Bros. merger because the increase was announced in November 2025 and implemented in January 2026, before the February 2026 merger agreement. Regarding the Skydance-Paramount merger, plaintiffs failed to allege a factual nexus between the merger and the price increase. Their "straightforward sequence" of changed control, new management, monetization strategy, and price increase lacked any factual connection between the alleged monetization strategy or transfer of control and reduced competition. The court held these "bare assertions" were too "vague and conclusory" to plead plausible antitrust injury.
As to generalized competitive harm, the court rejected plaintiffs' argument that consumers automatically have standing to challenge any horizontal merger. Citing Demartini v. Microsoft Corp., Dehoog v. Anheuser-Busch InBev, and recent Northern District cases Fry v. Capital One and Freeland v. Nippon Steel, the court held that plaintiffs must allege facts showing an "appreciable danger" or "reasonable probability" of anticompetitive effects in the relevant market. Plaintiffs' citations to broad ranges of FAC paragraphs describing "reduced incentives" and market conditions failed to identify any specific facts supporting their claims. Their conclusory allegations of threatened higher prices, reduced output, and diminished quality were insufficient under Twombly and Iqbal.
Key Takeaways
- Plaintiffs must allege specific facts linking a merger to a claimed price increase, not merely assert a temporal sequence of changed ownership, new management, and price hikes.
- A price increase implemented before a challenged merger cannot be attributed to that merger for standing purposes.
- Consumers do not have automatic antitrust standing to challenge any horizontal merger; they must plausibly allege an appreciable danger of anticompetitive effects in a defined relevant market.
- Conclusory allegations of "reduced incentives" and generalized competitive harm, without factual support regarding market share, concentration, or probable effects, fail to establish antitrust injury.
- The court granted leave to file a second amended complaint within 21 days but warned it is "very unlikely" to permit further amendment if deficiencies persist.
Why It Matters
This decision reinforces the heightened pleading standard for antitrust standing in private Section 7 merger challenges in the Northern District of California. Following Demartini, Fry, and Freeland, the court requires plaintiffs to move beyond boilerplate assertions that merger-driven consolidation inherently harms consumers. The ruling clarifies that post-merger pricing decisions must be factually tied to reduced competition flowing from the transaction itself—not merely to new management's business strategies—to constitute antitrust injury. The court's willingness to grant a second amendment opportunity reflects the Ninth Circuit's "extreme liberality" under Rule 15(a), but the explicit warning against further leave signals judicial impatience with iterative, unsubstantiated pleading.